Status:
COMPLETED
Risks of Bacterial and Fungal Superinfection in Patients With COVID-19
Lead Sponsor:
The University of Queensland
Collaborating Sponsors:
Merck Sharp & Dhome (Australia) Pty. Ltd.
Christian Medical College, Vellore, India
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Infection with bacteria or fungi can be deadly. Often, these types of infections can lead to an increase in the severity of illness requiring intensive care unit (ICU) admission, prolonged duration of...
Eligibility Criteria
Inclusion
- Hospital admission date from 1 July 2020 to 30 June 2021
- Positive test for COVID-19 collected within 1 week of admission date
- ICU admission within 60 days after hospital admission date
Exclusion
- Hospital admission shorter than 5 days
- Persons younger than 18 years of age
Key Trial Info
Start Date :
February 14 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 4 2022
Estimated Enrollment :
790 Patients enrolled
Trial Details
Trial ID
NCT05256316
Start Date
February 14 2022
End Date
December 4 2022
Last Update
May 22 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599
2
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia, 4029
3
Christian Medical College
Vellore, India, 632004
4
Tan Tock Seng Hospital
Singapore, Singapore